关注
Grigory Liubchenko
Grigory Liubchenko
Department of Nuclear Medicine, University Hospital, LMU Munich
在 med.uni-muenchen.de 的电子邮件经过验证
标题
引用次数
引用次数
年份
Biodistribution and dosimetry for combined [177Lu]Lu-PSMA-I&T/[225Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging
A Delker, M Schleske, G Liubchenko, I Berg, MJ Zacherl, M Brendel, ...
European journal of nuclear medicine and molecular imaging 50 (5), 1280-1290, 2023
272023
Investigation of image-based lesion and kidney dosimetry protocols for 177Lu-PSMA-I&T therapy with and without a late SPECT/CT acquisition
S Resch, S Takayama Fouladgar, M Zacherl, GT Sheikh, G Liubchenko, ...
EJNMMI physics 10 (1), 11, 2023
172023
Image-based dosimetry for [225Ac] Ac-PSMA-I&T therapy and the effect of daughter-specific pharmacokinetics
G Liubchenko, G Böning, M Zacherl, M Rumiantcev, LM Unterrainer, ...
European Journal of Nuclear Medicine and Molecular Imaging, 1-11, 2024
62024
Estimation of relative biological effectiveness of 225Ac compared to 177Lu during [225Ac]Ac-PSMA and [177Lu]Lu-PSMA radiopharmaceutical therapy using …
M Rumiantcev, WB Li, S Lindner, G Liubchenko, S Resch, P Bartenstein, ...
EJNMMI physics 10 (1), 53, 2023
32023
Expansion of a Small-Animal Proton CT Reconstruction Framework and Studies of Energy Dependence of Relative Stopping Power
G Hu, K Schnürle, S Meyer, G Liubchenko, J Bortfeldt, C Gianoli, K Parodi, ...
12021
Assessing the feasibility of high-Z metal (oxide) nanoparticles as contrast enhancement agents in proton imaging for a small animal irradiation platform
G Liubchenko, M Würl, K Schnürle, S Meyer, J Bortfeldt, C Granja, ...
12020
Investigating the co-registration of ionoacoustic and ultrasound signals along with possibilities of dose reconstruction in realistic small animal models for proton irradiation …
P Dash, J Lascaud, HP Wieser, R Kalunga, B Wollant, W Assmann, ...
12020
Gadolinium oxide nanoparticles as a multimodal contrast enhancement agent for pre-clinical proton imaging
M Würl, G Liubchenko, G Hu, K Schnürle, S Meyer, J Bortfeldt, G Landry, ...
Physics in Medicine and Biology, 2025
2025
Influence of patient motion on image-based dosimetry for 177Lu-PSMA therapy
S Resch, M Rumiantcev, G Liubchenko, M Brendel, SI Ziegler, G Boening, ...
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 51, S211-S211, 2024
2024
Optimizing 225Ac SPECT acquisition times by using a sparse view imaging protocol: a feasibility study
G Liubchenko, G Boening, M Zacherl, M Rumiantcev, GT Sheikh, ...
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 51, S163-S163, 2024
2024
PP31. 07 IMPACT OF SMALL PATIENT MOTION DURING 177Lu-PSMA SPECT/CT SCANS ONTO LESION DOSIMETRY BASED ON A PHANTOM SIMULATION STUDY
S Resch, M Rumiantcev, X Shen, G Liubchenko, SI Ziegler, G Böning, ...
Physica Medica 125, 103874, 2024
2024
PP31. 05 IMAGE-BASED BONE MARROW DOSIMETRY IN PATIENTS UNDERGOING [177Lu] Lu-PSMA RADIOPHARMACEUTICAL THERAPY
X Shen, M Rumiantcev, S Resch, G Liubchenko, SI Ziegler, G Böning, ...
Physica Medica 125, 103872, 2024
2024
SC18. 05 IMAGE-BASED DOSIMETRY FOR [225Ac] Ac-PSMA-I&T THERAPY AND THE EFFECT OF DAUGHTER-SPECIFIC PHARMACOKINETICS
G Liubchenko, G Böning, M Zacherl, M Rumiantcev, L Unterrainer, ...
Physica Medica 125, 103497, 2024
2024
SC04. 03 ENHANCING RADIATION PROTECTION FOR PERSONNEL, PATIENT RELATIVES, AND THE PUBLIC FOR PATIENTS RECEIVING RADIOPHARMACEUTICAL THERAPY–RESULTS OF THE EXPERT PROJECT
K Hürkamp, J Brosch-Lenz, A Delker, SSG Febles, S Großmann, ...
Physica Medica 125, 103445, 2024
2024
Patientenspezifische bildgestützte Dosimetrie für die [225Ac] Ac-PSMA-I&T-Therapie und unter Berücksichtigung der tochterspezifischen Pharmakokinetik
G Liubchenko, G Böning, M Zacherl, M Rumiantcev, LM Unterrainer, ...
Nuklearmedizin-NuclearMedicine 63 (02), V27, 2024
2024
Estimation of relative biological effectiveness of. sup. 225Ac compared to. sup. 177Lu during [. sup. 225Ac] Ac-PSMA and [. sup. 177Lu] Lu-PSMA radiopharmaceutical therapy …
M Rumiantcev, WB Li, S Lindner, G Liubchenko, S Resch, P Bartenstein, ...
EJNMMI Physics 10 (1), NA-NA, 2023
2023
Evaluierung der Pharmakokinetik von Bi-213 für die kombinierte Ac-225/Lu-177-PSMA-I&T-Therapie
G Liubchenko, M Rumiantcev, MJ Zacherl, FJ Gildehaus, A Harbach, ...
Nuklearmedizin-NuclearMedicine 62 (02), P45, 2023
2023
Vergleich verschiedener Methoden zur Einzelzeitpunktdosimetrie bei der 177Lu-PSMA Therapie in Abhängigkeit von Gewebetyp und Referenzmodell
S Resch, G Liubchenko, M Rumiantcev, M Zacherl, GT Sheikh, V Wenter, ...
Nuklearmedizin-NuclearMedicine 62 (02), L32, 2023
2023
Schätzung der relativen biologischen Wirksamkeit während der Ac-225-PSMA-und Lu-177-PSMA-Therapie vor und nach der DNS-Reparatur mittels TOPAS/TOPAS-nBio/MEDRAS [1-5]
M Rumiantcev, W Li, S Lindner, G Liubchenko, S Resch, P Bartenstein, ...
Nuklearmedizin-NuclearMedicine 62 (02), P26, 2023
2023
Investigation of the biodistribution and dosimetry for combined Lu-177/Ac225-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging
A Delker, M Schleske, G Liubchenko, I Berg, MJ Zacherl, M Brendel, ...
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 49 (SUPPL 1 …, 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–20